$18.22
-0.06 (-0.33%)
Open$18.04
Previous Close$18.28
Day High$18.52
Day Low$16.89
52W High$35.80
52W Low$9.10
Volume—
Avg Volume241.5K
Market Cap365.55M
P/E Ratio—
EPS$-4.58
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
-56.3% upside
Current
$18.22
$18.22
Target
$7.97
$7.97
$5.39
$7.97 avg
$9.61
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 515.2K | 555.0K | 44.14M |
| Net Income | -95,993,226 | -93,066,792 | -12,888,213 |
| Profit Margin | -158,800.0% | -150,860.0% | -29.2% |
| EBITDA | -97,679,426 | -99,962,786 | -17,594,581 |
| Free Cash Flow | — | — | -11,802,396 |
| Rev Growth | -7.2% | -7.2% | -3.2% |
| Debt/Equity | — | — | 0.27 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |